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Abstract
Background: Breast milk is the feed of choice for premature infants,
although its nutritional composition is not always sufficient to meet their
raised nutritional requirements. The addition of a multi-nutrient breast milk
fortifier (BMF) to breastmilk is recommended; however, international
guidelines on the use of BMF are inconsistent. The present study aimed to
explore the use of BMF in preterm infants by paediatric dietitians in the
UK.
Methods: A questionnaire was designed and sent to members of the British
Dietetic Association neonatal specialist group (n = 100) using a secure
online platform. Descriptive statistics were calculated.
Results: Forty dietitians completed the survey, all of whom used BMF. Local
hospital BMF guidelines were available to 77.5% (n = 31). The most com-
monly used criteria for commencing BMF were: tolerating a feed volume of
150 mL kg1 day1 (72.5%, n = 29), a gestational age <34 weeks (67.5%,
n = 27) and a birth weight <1500 g (60%, n = 24). The primary contraindi-
cation for the use of BMF was necrotising enterocolitis (NEC). The majority
of respondents used standard fortification, with individualised fortification
available to only 12.5% (n = 5). The most common indicators for discon-
tinuing BMF were on discharge home (67.5%, n = 27), satisfactory growth
(65%, n = 26) or feeding directly from the breast (62.5%, n = 25).
Conclusions: Although BMF is used more proactively in UK neonatal units
than previously, variation in practice remains. Individualised fortification is
very uncommon and caution remains regarding risk of NEC. The develop-
ment of national guidelines on the use of BMF would help to standardise
nutritional care in neonatal units.
Introduction
Infants born prematurely, defined as before 37 weeks of
gestation, are at increased nutritional risk. They are born
before the large accretion of nutrient stores occurs via
placental transfer in the third trimester of pregnancy (1).
They have less lean tissue than term infants (2); hence, the
principal aim of nutrition support in premature infants is
to simulate in utero growth (3,4). Inadequate nutrition can
result in compromised postnatal growth, particularly
poorer neurodevelopmental outcomes (5). By contrast, it
has been shown that postnatal growth failure in preterm
infants is not inevitable, when there is an emphasis on
improved nutritional care (6).
Providing optimal nutrition for preterm infants
remains a challenge with many unanswered questions,
particularly with regard to estimation of nutritional
requirements. Maternal breast milk is the preferred feed,
followed by donor expressed breast milk, provided from
women who deliver at term (1,4,7). Breast milk has numer-
ous benefits compared to preterm formula, namely it
contains immunoprotective factors, is protective against
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sepsis and necrotising enterocolitis, and has better nutri-
ent bioavailability (8,9). Breast milk adapts for prematu-
rity, containing higher levels of protein, energy and
micronutrients than mature breast milk from mothers
who deliver at term (7). However, the nutrient levels in
both preterm and mature breast milk do not always meet
the elevated nutritional requirements of preterm infants,
particularly for those born with a birth weight <1500 g
(1,3,4). Therefore, in developed countries, a multi-nutrient
breast milk fortifier (BMF) is often added to breast milk
to provide additional energy, protein, vitamins and min-
erals (1).
The use of BMF in preterm infants has been found to
have beneficial effects on bone mineralisation, weight
gain, and linear and head circumference growth (4); how-
ever, international guidance on its use has subtle differ-
ences (4,10-12), not least because preterm infants are a
heterogeneous group, born into different environments,
on a continuum of gestation, development and nutri-
tional status. In 2019, the European Milk Bank Associa-
tion published guidelines recommending for preterm
infants that nutrient fortification of human milk is
required to optimise growth; however, further research is
required to advance the type and method of fortification
(1). In the UK, BMF is used as part of standard feeding
practices in most neonatal units (7). It is administered as
a powder, mostly as a fixed dose sachet and available for
inpatient use only (13). Some specialist hospitals are
equipped with human milk analysers, which can measure
the exact nutritional composition of the breast milk given
to infants. Individualised fortification, either ‘targeted’ to
breast milk composition or ‘adjusted’ according to an
infant’s biochemistry, can then be used to supplement
with a precise quantity of nutrients required to meet the
infant’s requirements (1,14); however, this level of preci-
sion is not available in the majority of UK neonatal units
(14).
There are currently no national guidelines on when to
initiate or discontinue BMF, or what dose should be
given per day, potentially leading to inconsistent practices
across different neonatal units. A recent UK survey of
neonatology healthcare professionals illustrated a number
of widely held beliefs regarding the use of BMF, some of
which are not supported by current evidence (15). Simi-
larly, an international survey of neonatologists also
demonstrated marked variability in neonatal feeding prac-
tices, including the use of BMF (16). However, neither of
these two studies focused on practices by neonatal dieti-
tians, who play an essential role in assessing and enhanc-
ing the nutritional status of preterm infants as part of an
effective multidisciplinary neonatal team (17,18). The pre-
sent study therefore aimed to explore the use of BMF in
the UK by neonatal dietitians, with a specific focus on




Participants were recruited from the British Dietetic Asso-
ciation (BDA) neonatal specialist subgroup (n = 100). All
members of the BDA neonatal specialist subgroup were
eligible to participate provided that they worked with
neonatal patients in the UK at the time of completing the
survey. The survey was distributed to the groups’ mailing
list in May 2019 and remained open for 4 weeks, with a
reminder sent at the start of the third week. It was also
promoted via the official BDA paediatric group social
media accounts.
Survey design and piloting
A survey was constructed specifically for this study, based
on the study’s objectives and a comprehensive review of
the literature and similar studies (16,19). The survey was
piloted in April 2019 by six healthcare professionals with
neonatal experience. Feedback from respondents was pos-
itive, reporting that the survey was simple, having a logi-
cal flow of questions and appropriate language.
The final survey consisted of 18 questions and was
administered via an online platform ‘Online Surveys’
(https://www.onlinesurveys.ac.uk). It included preliminary
questions on workplace, clinical caseload and years of
work experience. Dichotomous questions determined
whether BMF was used as part of routine clinical practice
and the availability of local BMF guidelines. Multiple-
choice questions were then grouped into themes to mir-
ror the study objectives, containing hypothetical examples
on initiation of feeds, rate of increase in feeds and cessa-
tion of BMF. It also enquired about the use of micronu-
trient supplements. Further details are provided in the
Supporting information (File S1).
Statistical analysis
Data were exported to SPSS, version 24.0 (20). Quantitative
data were analysed using frequencies to describe trends in
practice. Differences in practice between the three levels
of neonatal units were explored using Fisher’s exact test.
P < 0.05 was considered statistically significant. Responses
to an open ended question were assessed and categorised
into themes.
Ethical approval was granted by the Faculty of Health
and Human Sciences Ethics Committee at University of
Plymouth prior to the recruitment of participants (refer-
ence number: 18/19-494, 18/19-514).
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Results
Response rate and occupational characteristics
In total, 40 neonatal dietitians completed the survey, indi-
cating a 40% response rate from potential participants.
Two participants did not complete the free text question,
listing clinical scenarios when breast milk fortifier would
be contraindicated. The remainder of respondents
answered all questions.
Neonatal units in the UK are categorised into three
levels to distinguish the level of specialist care they pro-
vide: level 3 Neonatal Intensive Care Units (NICU) look
after the most premature and unwell infants; level 2
(Local Neonatal Unit) units include high dependency
beds; and level 1 units also known as Special Care Baby
Units (SCBU) look after the most stable premature
infants. In our sample, over half of respondents worked
on level 3 NICUs, some of which had surgical units
(65%, n = 26). A quarter worked in level 2 neonatal
units (25%, n = 10), 5% (n = 2) worked in level 1
SCBUs and a further 5% (n = 2) selected the other
response option. The free text responses included a
neonatal unit incorporating all levels of care and one par-
ticipant was a neonatal network dietitian. Over half of
respondents (55%, n = 22) had greater than 5 years of
experience with this patient group. Some 42.5% of
respondents (n = 17) worked solely with neonatal
patients, with 90–100% of their workload dedicated to
this patient group.
Use of breast milk fortifier
All of the respondents (n = 40) used BMF. Local BMF
guidelines were available to 77.5% (n = 31) of respon-
dents and one participant used a neonatal network BMF
guideline. From a multiple response question, neonatolo-
gists or consultant paediatricians were most likely (95%,
n = 38) to commence BMF, followed by dietitians
(87.5%, n = 35) and registrars or speciality trainee doc-
tors (45%, n = 18).
Criteria for commencing breast milk fortifier
The following data describe responses from the multiple-
choice questions where participants could select more than
one answer. The free text answers to the ‘other’ response
options were assessed and, if it was felt they represented
one of the predetermined survey answers, then they were
coded to this. Answers that did not fit the predefined
response options were analysed separately and only disre-
garded if they did not answer the survey question.
A gestational age <34 weeks was most commonly used
age criteria for commencing BMF (67.5%, n = 27),
followed by a gestational age of <32 weeks (27.5%,
n = 11). There was no difference between level 2 and 3
neonatal units in the gestational age when BMF was com-
menced (P = 0.176).
The use of birth weight as a criterion to commence
BMF is shown in Fig. 1. It was commenced most fre-
quently in infants with a birth weight <1500 g (n = 24,
60%), followed by a third (32.5%, n = 13) of dietitians
using BMF with infants with extremely low birth weight
(birth weight <1000 g). Four participants (10%) selected
the other option, two of which specified a birth weight
<2 kg as their criteria for commencing BMF. However,
32.5% (n = 13) did not use birth weight as a criterion for
starting BMF.
Almost three-quarters (72.5%, n = 29) of dietitians
started BMF when a feed volume of 150 mL kg1 day1
had been established, with only 12.5% (n = 5) starting
at a volume of 120 mL kg1 day1. Five respondents
(12.5%) commenced BMF if at least 50% of the total
daily enteral feed volume was expressed breast milk. No
significant difference (P = 0.460) was found between level
2 and level 3 neonatal units and the volume of feed when
BMF was commenced.
Most (60%, n = 24) of respondents did not use age as
a criterion for commencing BMF, although 25% (n = 10)
did wait until the infant was at least 14 days old. BMF
was introduced by 57.5% (n = 23) of dietitians when an
infant’s weight gain fell below 15 g kg1 day1 and by
27.5% (n = 11) when an infant’s growth had faltered.
However, growth was not used in the assessment for
starting BMF by 32.5% (n = 13) of dietitians. Forty-five
percent (n = 18) of dietitians did not use serum bio-
chemistry levels to determine whether BMF was com-
menced, whereas 30% (n = 12) and 20% (n = 8) of
dietitians, respectively, commenced BMF when urea levels
fell below 2 mmol L1 or 4 mmol L1.
Starting dose of breast milk fortifier
Almost all respondents (87.5%, n = 35) used standard
fortification methods, with only 5% (n = 2) and 7.5%
(n = 3) of dietitians using targeted or adjusted fortifica-
tion, respectively (i.e. based on analysis of maternal breast
milk and monitoring biochemistry). Two dietitians com-
mented that they aspired to using targeted or adjusted
fortification but did not have sufficient time or equip-
ment to facilitate these methods. In our sample, BMF was
most commonly started by dietitians using a graded
introduction approach. Some 40% of respondents
(n = 16) recommended that BMF was introduced at half
strength for 24 h, where ‘half strength’ equates to 50% of
the dose of BMF recommended by manufacturers dis-
solved in 100 mL of expressed breast milk (EBM). 22.5%
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(n = 9) of respondents extended the ‘half strength’ graded
introduction to 48 h.
Monitoring of biochemistry and micronutrient
supplementation
Serum biochemistry was monitored routinely by 85%
(n = 34) of dietitians when preterm infants received BMF
in hospital. No neonatal teams conducted routine bloods
on infants on BMF once discharged from hospital.
The multiple-choice responses on the use of micronu-
trients indicated that multivitamins (72.5%, n = 29) and
iron (75%, n = 30) were given most commonly alongside
BMF. This was followed by phosphate (32.5%, n = 13),
folic acid (20%, n = 8) and vitamin D (12.5%, n = 5).
Three dietitians (7.5%) only gave additional micronutri-
ent supplementation if indicated by the infants’ biochem-
istry results or clinically indicated. Two dietitians (5%)
did not recommend any additional vitamin or mineral
supplements to preterm infants on BMF.
Contraindications for the use of breast milk fortifier
The free text responses (n = 38) to when BMF was con-
traindicated were grouped into eleven different themes
(Table 1). Participants could list more than one con-
traindication. Necrotising enterocolitis (NEC), either con-
firmed or suspected, was cited as the most common
reason for not using BMF (n = 24), followed poor toler-
ance or suspected cows’ milk protein allergy (n = 12).
Discontinuation of breast milk fortifier
BMF was stopped by 50% (n = 20) of dietitians on dis-
charge from the neonatal unit, with 7.5% (n = 3) using it
‘rarely’ on discharge. Only one dietitian (2.5%) routinely
continued BMF on discharge, with two (5%) using a
reduced dose. 35% (n = 14) of dietitians would recom-
mend continuing BMF if the infant required it clinically.
The main indicators for discontinuing BMF (Fig. 2)
were on discharge home (67.5%, n = 37), closely followed
by satisfactory growth as indicated by tracking growth
centile lines (65%, n = 26) or feeding directly from the
breast (62.5%, n = 25).
Discussion
The present study explored the use of BMF by neonatal
dietitians in the UK, with a specific focus on the criteria
used to initiate and discontinue BMF, biochemical moni-
toring and contraindications. The results show that all
respondents used BMF routinely in preterm infants,
which is higher than previously reported in 2012, when
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Figure 1 Birth weight used as a criterion for starting breast milk fortifier (BMF). IUGR, In utero growth restriction.
Table 1 Clinical scenarios when breast milk fortifier (BMF) would be




NEC/suspected NEC/distended abdomen 24
Poor tolerance/suspected cows’ milk protein
allergy
12







Absent/reversed end diastolic flow (abnormal
placental blood flow)
2
Complex congenital cardiac defects 1
Weight less than 1000 g and on >50%
parenteral nutrition
1
Less than 32 weeks of gestation 1
Close to discharge and BMF unavailable in the
community
1
Term infant or weight greater than 2.5 kg 1
NEC, necrotising enterocolitis.
*Respondents could list more than one reason for withholding BMF.
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part of standard practice (16). There was no disparity in
the use of BMF between levels of neonatal unit, in con-
trast to a previous finding that BMF was used more com-
monly in level 2 versus level 3 neonatal units (15). Most
neonatal units (77.5%) had guidelines on the use of
BMF, which is greater than the 49% previously identified
(15). Overall, the present study has demonstrated a posi-
tive change in dietetic practice. BMF is commenced
proactively to optimise an infant’s nutritional status in all
levels of neonatal care, rather than postponing usage until
there is a decline in nutritional status. However, some
inconsistencies and limitations in practice remain, with a
cautious approach in relation to the risk of NEC and
scarce use of targeted fortification.
The study surveyed the practices of neonatal dietitians
in the UK. All respondents were members of the neona-
tal specialist subgroup of the BDA, a specialist subgroup
of the national professional body. Typically dietitians
working in neonatal units work as part of a multidisci-
plinary team including physicians, nurses, pharmacists
and other allied health professionals, an approach which
has been shown to be effective (18). The exact responsi-
bility for who makes decisions about nutritional input
will vary across different hospitals; generally they are
dietetic-led, although made in conjunction with the
multidisciplinary team. For example, in the present
study, consultant neonatologists/paediatricians (95%),
followed closely by dietitians (87.5%), were most likely
to recommend starting BMF, although we did not
explore the decision-making process any further. The
evolving nature of neonatal dietetics has led to debate
and discussion within the specialty about best practice
and the need for a competence framework (21). The situ-
ation is complicated by the inequality of dietetic service
between regions, at different levels of neonatal unit. As
such, the BDA neonatal specialist group has published a
competency framework that outlines the specific skills
and training needed by dietitians working on all levels
of neonatal care unit (21). Aligned to this, nationally
endorsed staffing recommendations for all levels of
neonatal unit have been developed to ensure that babies
and their families receive the best level of care wherever
they are treated (22).
There remains a variation in practice for the initiation
of BMF; however, the most commonly cited criterion was
volume of enteral feeds tolerated, which was closely fol-
lowed by gestational age at birth, birth weight and rate of
growth. Specifically tolerating 150 mL kg1 day1 of ent-
eral feeds, being born before 34 weeks of gestation, hav-
ing a birth weight <1500 g and gaining <15 g kg1 day1
were the most common indicators for starting BMF.
Actual age and biochemistry were the least commonly
used criteria in the present study. This change in practice
from a previous international study (16) to include the
volume of enteral feeds as one of the main criteria for
starting BMF could be attributed to wanting to minimise
the risk of NEC, by delaying the introduction of BMF
until the infant has reached what is considered as a ‘safe’
enteral feed volume. The reported disparities in practice
are reflective of differences between international guide-
lines. For example, the practice of commencing BMF in
infants weighing <1500 g at birth aligns with guidance
from the American Academy of Pediatrics (10), whereas
the European Society of Paediatric Gastroenterology,
Hepatology and Nutrition (ESPGHAN) recommend a
birthweight < 1800 g as a criterion (8). A minority of
respondents (27.5%, n = 11) reported using faltering
growth as a criterion for commencing BMF, as is recom-
mended by the World Health Organization (10) in 2011,
which is no longer considered best practice. However, the
majority of dietitians started BMF as soon as the preterm
infant started showing signs of suboptimal weight gain
(<15 g kg1 day1). As a consequence of the way that
the survey questions were posed, it was not possible to
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Figure 2 Criteria for discontinuing breast milk fortifier (BMF). EBM, expressed breast milk.
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The majority of respondents (85%, n = 34) routinely
monitored serum biochemistry when preterm infants
were receiving BMF in hospital. Almost all dietitians used
standard fortification methods, with only 12.5% (n = 5)
using targeted and adjusted fortification of breast milk,
possibly because most neonatal units do not have access
to breast milk analysers (15). Standard fortification
remains the most widely used fortification method; how-
ever, this does not address the issue of protein undernu-
trition in very low birthweight infants (1). It is
recommended that fortification should start with standard
fortification; however, if infants do not grow appropri-
ately, individualised fortification is advisable (either
adjustable or targeted), depending on the neonatal unit’s
experience and facilities (4). Targeted fortification means
that all macronutrients can be supplemented, potentially
resulting in a more balanced composition and consistent
intake of fat, proteins, and carbohydrates (14). Although it
has been shown to be feasible (14), targeted fortification
requires a milk analyser, which requires careful calibra-
tion (1) and also requires real-time measurements, esti-
mated to take an additional workload of approximately
5-10 min per milk batch once practitioners have been
trained (14). As it stands, a recent survey indicated that
targeted fortification was only available on 36% of UK
neonatal units (15), suggesting that there is significant
room for improvement; however, this would be depen-
dent on further resources and training being made avail-
able on an institutional level. Of note, a recent National
Health Service strategy document about improving
neonatal care advises that ‘all staff are given formal learn-
ing opportunities to ensure that staff are adequately
trained to undertake their role responsibilities’ (23).
Respondents reported that multivitamins (72.5%), iron
(75%), phosphate (32.5%), folic acid (20%) and vitamin
D (12.5%) were given routinely alongside BMF. However,
the questions did not distinguish whether supplementa-
tion differed depending on the strength of BMF being
administered. The low rates of vitamin D supplementa-
tion in our sample are somewhat surprising, despite both
brands of BMF not meeting the very high preterm vita-
min D requirements (20–25 lg day1) set by ESPGHAN
(1). This could be the result of a reliance on historic vita-
min D supplementation recommendations of 10 lg day1
per day from 2005 (24).
NEC and suspected NEC were listed as the most com-
mon contraindications to using BMF. NEC is a severe
inflammatory gastrointestinal condition, requiring surgery
in 20–40% of cases, and is fatal in 25–50% of cases (25).
There are multiple factors that may contribute to NEC,
with different types of nutrition affecting its onset and
progression (25). Although BMF derived from human
breast milk is available in some countries (4), the available
BMF in the UK is derived from bovine sources. The use
of human fortified breast milk has been shown to reduce
the risk of NEC compared with bovine-based fortified
breast milk in a study of extremely premature infants (26);
however, it is not clear why some infants fed exclusively
breast milk still develop NEC (25). Our finding implies
that dietetic practice remains cautious. This is despite evi-
dence of no increased risk of NEC with the introduction
of BMF at the infant’s first feed or when fed
20 mL kg1 day1 of EBM, compared to delaying fortifi-
cation until the infant was established on larger volumes
of EBM (27,28). The cautious approach of delaying fortifi-
cation until feed volumes reach 100 mL kg1 day1 has
been heavily criticised as lacking in evidence, being futile
and ultimately delaying delivery of full nutrient require-
ments (29). Similar to our findings, another UK-based
study of predominantly neonatal nurses reported that
43% agreed ‘BMF can be implicated in the pathogenesis
of NEC’ (11). However, 84% agreed that ‘BMF is safe for
the majority of preterm infants’ and 72% agreed that it
‘is well tolerated by preterm infants’ (15). These findings
emphasise the need to improve knowledge and ensure
practice is based on current evidence.
Poor tolerance or suspected cow’s milk protein allergy
was the second most common free text response
(n = 12) for withholding BMF. In preterm infants, cows’
milk protein allergy often presents as non-specific gas-
trointestinal symptoms, making it difficult to distinguish
from poor feed tolerance, which is common as a result
of gut immaturity (30). Of note, both BMFs used in the
UK are bovine-based, although the degree of protein
hydrolysis differs. Fortifiers based on human breastmilk
are available in other countries. Optimising human milk-
based fortifiers, bioengineered to contain as many bioac-
tive products as possible (4), in addition to further
research on development of NEC, may mitigate some of
the concerns surrounding feed-related issues and causa-
tion of NEC.
In the present study, the most commonly cited reason
for discontinuation of BMF was when an infant was dis-
charged home (67.5%, n = 27), rather than based on a
reaching a target weight. Although ESPGHAN recom-
mends that preterm infants with a suboptimal weight
should continue to have BMF following discharge home
from hospital (31), more recent guidelines from 2019 con-
clude there is no consensus on post-discharge nutrition
(1). From a practical perspective, in the UK, BMF is not
available on prescription in the community, although
35% (n = 14) of our respondents would continue BMF at
home if clinically indicated. The inaccessibility of BMF
for infants once discharged home means optimal dietetic
care planning to support some infants who may need
continued nutritional support is not always feasible.
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The next most commonly cited reasons for cessation of
BMF were when the infants’ weight was tracking a centile
line (65%, n = 26) or when infants were feeding directly
from the breast (62.5%, n = 25). Although these findings
are consistent with results from a previous survey in the
UK and Ireland (14), it is surprising that feeding directly
from the breast is one of the most common criteria for
ceasing the use of BMF. BMF can be administered in a
concentrated format orally prior to a breast feed, com-
monly known as a BMF ‘shot’, although some feel that
this interferes with breast feeding and may prevent moth-
ers from continuing to breastfeed exclusively (15). A
Cochrane review from 2013 identified only two small tri-
als (32,33) comparing feeding preterm infants with BMF
fortified breast milk to unfortified breast milk following
hospital discharge, with no long-term data past
18 months of age (34). Neither trial found a statistically
significant difference in the overall duration of breastmilk
feeding; however, one of the studies reported that statisti-
cally significantly fewer infants in the BMF group
remained exclusively breastfed (no formula) at 4 months
(33). Subsequently, a UK-based quality improvement study
has demonstrated that the growth trajectory of exclusively
breastfed preterm infants discharged home on BMF was
improved up to 1 year of age, with parents and health-
care professionals finding the use of home BMF supple-
ment to be acceptable, feasible and safe (13). Overall, there
is an absence of evidence on the effect of using BMF
post-discharge on long-term growth and developmental
outcomes beyond 1 year corrected age and it is recom-
mended that any future interventions are developed in
conjunction with families and consider the potential for
interference on breastfeeding (34).
Strengths and limitations
As a result of the absence of a national database for dieti-
tians, it was a challenge to identify all paediatric dietitians
working with preterm infants; hence, purposive recruit-
ment was conducted via the BDA neonatal specialist sub-
group. Membership of this group is voluntary; therefore,
it was not possible to reach all practitioners. Our
response rate of 40% was reasonable, although a higher
rate would have made the results more externally general-
isable. A longer response window or different method of
distributing the survey may have elicited a higher
response rate. A previous survey of the same specialist
group had a higher response rate (66%) but a lower
number of respondents (n = 27) (13). Previous studies on
the use of BMF in other healthcare professionals have eli-
cited a wide variation in response rates, from an excep-
tional online response rate of 98% (14) compared to 26%
in a postal survey (15). A strength of the study is the
specific focus on dietetic practice. Future research using a
mixed-methods design or qualitative approach would
enable further details to be explored, given that preterm
infants are a heterogeneous group and investigating every
permutation is not possible with a questionnaire-based
study. It would also be useful to assess whether the diete-
tic time allocated to a neonatal unit or per neonatal cot
influenced the use of BMF and growth outcomes.
Conclusions
In summary, BMF was used routinely by all respondents,
across all three levels of neonatal unit, and was com-
menced proactively before an infants’ nutritional status
had been compromised. However worryingly, some nutri-
tional practices are outdated and overly cautious, meaning
that infants may be discharged with suboptimal nutri-
tional input. The criteria used to commence BMF varied,
although it was most commonly commenced in infants
tolerating 150 mL kg1 day1 of enteral feeds, born
before 34 weeks of gestation, in those with a birth weight
<1500 g and gaining <15 g kg1 day1. NEC or suspected
NEC was the most commonly cited contraindication to
introducing BMF. Targeted and adjusted fortification was
only available to 12.5% of respondents. BMF was most
often discontinued when an infant was discharged home
or feeding at the breast. BMF guidelines are not available
in all neonatal units across the UK, which may explain the
differing practices. The development of national guidelines
on the use of BMF, alongside investment in development
of dietetic services and more widespread use of breast milk
analysers, would help to standardise and improve nutri-
tional management in neonatal units.
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